Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Antibodies, Viral/*immunology"'
Autor:
Tanya Golubchik, Anthony C. Gordon, Rutger J. Ploeg, Ullrich Leuscher, Wendy Slack, Pat Tsang, Manu Shankar-Hari, David K. Menon, Paul R Mouncey, Sarah Williams, Lise J Estcourt, Sheba Ziyenge, Farah Al-Beidh, Heli Harvala, Nick A Ciccone, Peter Simmonds, David J. Roberts, Jeremy Ratcliff, Kathryn M Rowan, Abigail Lamikanra, Jennifer Rynne, Amy Evans, Dung Nguyen, Aislinn Jennings, Matthew Fish, Emma Laing, David Bonsall, Marta S Oliveira
Publikováno v:
2021, ' Virological Characterization of Critically Ill Patients With COVID-19 in the United Kingdom : Interactions of Viral Load, Antibody Status, and B.1.1.7 Infection ', The Journal of Infectious Diseases, vol. 224, no. 4, pp. 595-605 . https://doi.org/10.1093/infdis/jiab283
BackgroundConvalescent plasma containing neutralizing antibody to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is under investigation for coronavirus disease 2019 (COVID-19) treatment. We report diverse virological characteristics of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3935a99113299cb16abdecddfb35876e
https://doi.org/10.1093/infdis/jiab283
https://doi.org/10.1093/infdis/jiab283
Autor:
Okba, Nisreen M A, Widjaja, Ivy, van Dieren, Brenda, Aebischer, Andrea, van Amerongen, Geert, de Waal, Leon, Stittelaar, Koert J, Schipper, Debby, Martina, Byron, van den Brand, Judith M A, Beer, Martin, Bosch, Berend-Jan, Haagmans, Bart L, LS Virologie, VPDC pathologie, dPB I&I, dPB CR, Virologie, dI&I I&I-1
Publikováno v:
Emerging Microbes & Infections
article-version (VoR) Version of Record
Emerging Microbes & Infections, 9(1), 1080-1091. Nature Publishing Group
Emerging Microbes and Infections, 9(1), 1080. Nature Publishing Group
article-version (VoR) Version of Record
Emerging Microbes & Infections, 9(1), 1080-1091. Nature Publishing Group
Emerging Microbes and Infections, 9(1), 1080. Nature Publishing Group
Middle East respiratory syndrome coronavirus (MERS-CoV) is a WHO priority pathogen for which vaccines are urgently needed. Using an immune-focusing approach, we created self-assembling particles multivalently displaying critical regions of the MERS-C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d54e38734d6f4b8ad3638de9917f8800
http://europepmc.org/articles/PMC7448924
http://europepmc.org/articles/PMC7448924
Autor:
Filipe Ferreira, Margarida Archer, Maria João Amorim, Diogo Athayde, Fátima Serrano, Helena Soares, A. Margarida Juliano, Nádia Charepe, Marta Alenquer, Juliana Gonçalves
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Cell Reports Medicine
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Cell Reports Medicine
In view of the scarcity of data to guide decision making, we evaluated how BNT162b2 and mRNA-1273 vaccines affect the immune response in lactating women and the protective profile of breastmilk. Compared with controls, lactating women had a higher fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0697d0233892737494159ff341ef8be
Publikováno v:
British Journal of Clinical Pharmacology
SARS‐CoV‐2 mutacije predstavljaju jako veliki problem za učinkovitost terapije monoklonalnim antitijelima.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc5a7f3e47edd49d87d1a8fb436ad530
https://urn.nsk.hr/urn:nbn:hr:105:329087
https://urn.nsk.hr/urn:nbn:hr:105:329087
Autor:
Mario Habek, Koraljka Đurić, Alenka Horvat Ledinek, Ivana Lapić, Tereza Gabelić, Nevena Grbić, Gregor Jakob Brecl, Dunja Rogić, Vanja Bašić Kes, Ivan Adamec, Magdalena Krbot Skorić, Andreja Emeršič, Dragana Šegulja, Barbara Barun
Publikováno v:
Journal of Neuroimmunology
Aim To determine the influence of high-efficacy disease modifying therapy (DMT) on the development of IgG SARS-CoV-2 antibody response in COVID-19 convalescent people with multiple sclerosis (pwMS). Methods Seventy-four pwMS taking high-efficacy DMTs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23727aafa3f2fce8621d988211ff9593
https://urn.nsk.hr/urn:nbn:hr:105:017413
https://urn.nsk.hr/urn:nbn:hr:105:017413
Autor:
Kennedy, Nicholas A, Goodhand, James R, Bewshea, Claire, Nice, Rachel, Chee, Desmond, Lin, Simeng, Chanchlani, Neil, Butterworth, Jeffrey, Cooney, Rachel, Croft, Nicholas M, Hart, Ailsa L, Irving, Peter M, Kok, Klaartje B, Lamb, Christopher A, Limdi, Jimmy K, Macdonald, Jonathan, McGovern, Dermot Pb, Mehta, Shameer J, Murray, Charles D, Patel, Kamal V, Pollok, Richard Cg, Raine, Timothy, Russell, Richard K, Selinger, Christian P, Smith, Philip J, Bowden, Jack, McDonald, Timothy J, Lees, Charlie W, Sebastian, Shaji, Powell, Nicholas, Ahmad, Tariq, Contributors To The CLARITY IBD Study
Publikováno v:
2021, ' Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab ', Gut, vol. 70, no. 5, pp. 865-875 . https://doi.org/10.1136/gutjnl-2021-324388
Gut
Gut
ObjectiveAntitumour necrosis factor (anti-TNF) drugs impair protective immunity following pneumococcal, influenza and viral hepatitis vaccination and increase the risk of serious respiratory infections. We sought to determine whether infliximab-treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b6e01dd054652cb9b8697520d2d594a
https://hdl.handle.net/20.500.11820/1bfd49d0-2ff9-4251-9b80-3c64409dface
https://hdl.handle.net/20.500.11820/1bfd49d0-2ff9-4251-9b80-3c64409dface
Autor:
Vono, Maria, Huttner, Angela, Lemeille, Sylvain, Martinez-Murillo, Paola, Meyer, Benjamin, Baggio, Stephanie, Sharma, Shilpee, Thiriard, Anais, Marchant, Arnaud, Godeke, Gert-Jan, Reusken, Chantal, Alvarez, Catia, Perez-Rodriguez, Francisco, Eckerle, Isabella, Kaiser, Laurent, Loevy, Natasha, Eberhardt, Christiane S., Blanchard-Rohner, Geraldine, Siegrist, Claire-Anne, Didierlaurent, Arnaud M.
Publikováno v:
Cell reports, Vol. 37, No 1 (2021) P. 109773
Cell Reports
Cell Reports, Vol 37, Iss 1, Pp 109773-(2021)
Cell reports, 37 (1
Cell Reports
Cell Reports, Vol 37, Iss 1, Pp 109773-(2021)
Cell reports, 37 (1
SARS-CoV-2 infection in children is less severe than it is in adults. We perform a longitudinal analysis of the early innate responses in children and adults with mild infection within household clusters. Children display fewer symptoms than adults d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::24e195196f58949537d65c6edc4172e8
https://archive-ouverte.unige.ch/unige:158928
https://archive-ouverte.unige.ch/unige:158928
Autor:
Bahaa Abu-Raya, Shabir A. Madhi, Saad B. Omer, Gayatri Amirthalingam, Michelle L. Giles, Katie L. Flanagan, Petra Zimmermann, Miguel O’Ryan, Marco A. Safadi, Vassiliki Papaevangelou, Kirsten Maertens, Nasamon Wanlapakorn, Vicens Diaz-Brito, Eline Tommelein, Susanna Esposito
Publikováno v:
Frontiers in immunology
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy is associated with a higher risk for severe morbidity and mortality when compared with infection in non-pregnant women of childbearing age. An increasing number of co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::929d0d8d0254ccb2bbf13e172d609140
https://hdl.handle.net/10067/1855310151162165141
https://hdl.handle.net/10067/1855310151162165141
Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infections often cause only mild disease that may evoke relatively low Ab titers compared with patients admitted to hospitals. Generally, total Ab bridging assays combine good sensitivity wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______101::2b67513f787097796abf2458595c712e
https://dspace.library.uu.nl/handle/1874/410431
https://dspace.library.uu.nl/handle/1874/410431
Autor:
Chun-Hong Chen, Stephanie Gamez, James E. Crowe, Prasad N. Paradkar, Jean-Bernard Duchemin, Igor Antoshechkin, Shin-Wei Wang, Anna Buchman, Omar S. Akbari, Shin-Hang Lee, Ming Li, Melissa J. Klein
Publikováno v:
PLoS Pathogens
PLoS Pathogens, Public Library of Science, 2020, 16 (1), pp.e1008103. ⟨10.1371/journal.ppat.1008103⟩
PLoS Pathogens, Vol 16, Iss 4, p e1008545 (2020)
PLoS Pathogens, Vol 16, Iss 1, p e1008103 (2020)
PLoS pathogens, vol 16, iss 4
PLoS pathogens, vol 16, iss 1
PLoS Pathogens, Public Library of Science, 2020, 16 (1), pp.e1008103. ⟨10.1371/journal.ppat.1008103⟩
PLoS Pathogens, Vol 16, Iss 4, p e1008545 (2020)
PLoS Pathogens, Vol 16, Iss 1, p e1008103 (2020)
PLoS pathogens, vol 16, iss 4
PLoS pathogens, vol 16, iss 1
With dengue virus (DENV) becoming endemic in tropical and subtropical regions worldwide, there is a pressing global demand for effective strategies to control the mosquitoes that spread this disease. Recent advances in genetic engineering technologie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc8c372de791b7b8e5641cb2255721e8
https://hal-pasteur.archives-ouvertes.fr/pasteur-02653696
https://hal-pasteur.archives-ouvertes.fr/pasteur-02653696